Drugs / IO102-103
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT05977907 | Dec 2023 → Oct 2026 expected | head and neck squamous cell carcinoma | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | Recruiting | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | IO102-103 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT05977907 ↗ |
| Route | Subcutaneous | “IO102-103 ( Subcutaneous injection weekly x6)” NCT05977907 ↗ |